Next, we developed a STEAP2-specific rabbit polyclonal IHC reagent to evaluate the prevalence and localization of protein expression in broad tissue microarrays (TMAs), where high, homogeneous expression levels were found to be restricted to prostate tumors (Figure 1A and Supplemental Figure 2). This evidence concerns the gene STEAP2 and prostate neoplasm.